Physician profile

Marshall D Shaw

Urology · Oklahoma City, OK

NPI 1225442841

$6,697.64

in general payments reported to CMS, 2019-2025

51 companies · $919 in 2025

The $919 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).

See the full distribution for Urology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$2,593.67
Education$220.10

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boston Scientific Corporation $2,321.90 2019-2025 Spaceoar System, Axonics, Spaceoar Vue System - 10ml
Astellas Pharma US INC $579.86 2019-2024 Xtandi
Sumitomo Pharma America, INC. $308.83 2023-2025 Orgovyx, Gemtesa
Teleflex LLC $302.01 2021-2025 Urolift, Barrigel
Myriad Genetic Laboratories, INC. $247.02 2020-2025 Prolaris, Myrisk
Procept Biorobotics Corporation $235.73 2024-2025 Aquabeam System
Abbvie INC. $204.77 2020-2025 Lupron Depot
Coloplast Corp $172.25 2019-2025
Medtronic, INC. $139.17 2021-2025 Interstim
Endo Pharmaceuticals INC. $135.71 2019-2022
Healthtronics Stone Solutions, LLC $125.44 2019
Pfizer INC. $120.71 2019-2025
Accord Healthcare, INC. $114.61 2023-2025
Urogen Pharma, INC. $113.35 2021-2025 Jelmyto
Axonics, INC. $112.85 2020-2024 Axonics, Bulkamid
Show all 51 companies
CompanyGeneral paymentsYearsTop products
Cook Medical LLC $96.59 2021-2025 Resonance, Cook, Litho 150
Endo USA, INC. $86.94 2024-2025 Xiaflex
Calyxo, INC. $84.10 2025 Cvac Aspiration System
Ferring Pharmaceuticals INC. $82.09 2024-2025 Adstiladrin
Intuitive Surgical, INC. $80.67 2022-2023
Myovant Sciences INC. $79.95 2021-2022
Astrazeneca Pharmaceuticals LP $67.95 2022-2025 Imfinzi
Janssen Biotech, INC. $67.91 2019-2023 Erleada
Neotract INC. $60.25 2019-2020
Ambu INC. $59.03 2020-2025
Sobi, INC $55.25 2022-2023
Novartis Pharmaceuticals Corporation $48.24 2023-2024
Allergan, INC. $45.22 2020-2021
Olympus America INC. $40.49 2025 Itind System
Blue Earth Diagnostics $40.37 2022
Civco Medical Instruments $39.46 2025
Travere Therapeutics, INC. $37.03 2021-2022
Urovant Sciences INC $35.62 2022
Tolmar Pharmaceuticals, INC. $35.39 2020-2021
Tolmar, INC. $31.99 2024-2025 Eligard, Jatenzo
Rigel Pharmaceuticals, INC. $31.61 2023 Tavalisse, Rezlidhia
Genzyme Corporation $30.48 2022
Tersera Therapeutics LLC $25.40 2022
Ethicon US, LLC $20.34 2025 Stratafix
Karl Storz Endoscopy-America $18.70 2023
Amgen INC. $18.21 2023 Vectibix, Xgeva, Nplate
Siemens Medical Solutions USA, INC. $17.68 2022
Merck Sharp & Dohme LLC $16.85 2021
Emd Serono, INC. $16.69 2022
Medtronic USA, INC. $14.83 2020
Laborie Medical Technologies Corp. $13.87 2024 Optilume Bph Drug Coated Balloon Catheter
Hollister Incorporated $13.81 2023 Onli, Infyna Chic, Vapro Pocket
Antares Pharma, INC. $13.38 2021
Dendreon Pharmaceuticals LLC $13.27 2019
Bard Access Systems, INC. $12.58 2019
Seagen INC. $11.19 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Marshall D Shaw

$6,697.64

in general payments reported 2019-2025

Years
2019-2025
Top company
Boston Scientific Corporation
Context
The $919 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).

https://glasscript.com/doctor/1251937/marshall-d-shaw

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.